After confirming that the mice had remained tumor-free for 5 weeks, we assessed the functional recall capabilities of the remaining human EphA3 CAR T cells by conducting a contralateral orthotopic rechallenge experiment. The gene discussed is EPHA3; the disease is neoplasm.